The eighteenth month, and the conversation that should have happened in the third
Weight reduction in the long programmes flattens at roughly sixty to seventy-two weeks. The timing is consistent, predictable and almost never mentioned in advance.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 18 of 18 of this archive, newest first.
Weight reduction in the long programmes flattens at roughly sixty to seventy-two weeks. The timing is consistent, predictable and almost never mentioned in advance.
These agents produce no dependence and no withdrawal syndrome. What a taper would be for is therefore a real question rather than an obvious one.
A withdrawal trial answers a narrower question than it appears to. This piece states which question.